(Q48496247)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

editorial

0 references

title

Making a case for albumin – a highly promising drug-delivery system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Zaklina Kovacevic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Des R. Richardson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Darius Lane

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Michael Huang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Sumit Sahni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

4

Patric J Jansson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1

Angelica M Merlot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

Future Medicinal Chemistry

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

553-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

Unraveling the mysteries of serum albumin-more than just a serum protein.

6 March 2020

cites work

1 reference

Relevance of albumin in modern critical care medicine

21 January 2018

1 reference

Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles

21 January 2018

1 reference

Clinical impact of serum proteins on drug delivery

21 January 2018

1 reference

A clinical update of using albumin as a drug vehicle - a commentary

21 January 2018

1 reference

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

A review of the pharmacological properties of insulin degludec and their clinical relevance

21 January 2018

1 reference

The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive review

21 January 2018

1 reference

Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.

21 January 2018

1 reference

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model

21 January 2018

1 reference

Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3.

21 January 2018

1 reference

A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy

21 January 2018

1 reference

Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma

21 January 2018

1 reference

Albinterferon-alfa 2b: a new treatment option for hepatitis C

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/FMC.15.15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25921396%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference